Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer’s disease co-pathology and behavior impairments
Neuron · 2024-11 · 112 (21) · 3585-3601.e5
DOI: 10.1016/j.neuron.2024.08.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2024-11. Verfasst von Jie Xiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Fourth Military Medical University, Xi'an 710032, China. Electronic address: xj890119@fmmu.edu.cn. Hauptthemen laut MEDLINE: alpha-Synuclein, tau Proteins, Mice, Transgenic, Parkinson Disease. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Postdoctoral Program for Innovative Talents, Young Star of Science and Technology in Shaanxi Province.
Themen: Demenz
Abstract (Originalsprache)
Tau interacts with α-Synuclein (α-Syn) and co-localizes with it in the Lewy bodies, influencing α-Syn pathology in Parkinson's disease (PD). However, whether these biochemical events regulate α-Syn pathology spreading from the gut into the brain remains incompletely understood. Here, we show that α-Syn and Tau co-pathology is spread into the brain in gut-inducible SYN103+/- and/or TAU368+/- transgenic mouse models, eliciting behavioral defects. Gut pathology was initially observed, and α-Syn or Tau pathology was subsequently propagated into the DMV or NTS and then to other brain regions. Remarkably, more extensive spreading and widespread neuronal loss were found in double transgenic mice (Both) than in single transgenic mice. Truncal vagotomy and α-Syn deficiency significantly inhibited synucleinopathy or tauopathy spreading. The α-Syn PET tracer [18F]-F0502B detected α-Syn aggregates in the gut and brain. Thus, α-Syn and Tau co-pathology can propagate from the gut to the brain, triggering behavioral disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Fourth Military Medical University, Xi'an 710032, China. Electronic address: xj890119@fmmu.edu.cn.
- Department of Neurobiology, Fourth Military Medical University, Xi'an 710032, China.
- Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Neurobiology, Fourth Military Medical University, Xi'an 710032, China. Electronic address: shengxi@fmmu.edu.cn.
- Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology (SUAT), Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China. Electronic address: kq.ye@siat.ac.cn.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- National Postdoctoral Program for Innovative Talents
- Young Star of Science and Technology in Shaanxi Province
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Xiang, J., Tang, J., Kang, F., Ye, J., Cui, Y., Zhang, Z., Wang, J., Wu, S., & Ye, K. (2024). Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer’s disease co-pathology and behavior impairments. Neuron, 112(21), 3585-3601.e5. https://doi.org/10.1016/j.neuron.2024.08.003
Vancouver
Xiang J, Tang J, Kang F, Ye J, Cui Y, Zhang Z, et al. Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer’s disease co-pathology and behavior impairments. Neuron. 2024;112(21):3585-3601.e5. doi:10.1016/j.neuron.2024.08.003
BibTeX
@article{Xiang2024,
author = {Xiang, Jie and Tang, Jingrong and Kang, Fei and Ye, Jiajun and Cui, Yueying and Zhang, Zhentao and Wang, Jing and Wu, Shengxi and Ye, Keqiang},
title = {Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer’s disease co-pathology and behavior impairments},
journal = {Neuron},
year = {2024},
volume = {112},
number = {21},
pages = {3585--3601.e5},
doi = {10.1016/j.neuron.2024.08.003}
}
EUVIMED